Printer Friendly

Hypermobility increases risk of osteoporosis.

Patients with hypermobility have a significant and often unappreciated risk of osteoporosis. The prevalence of osteopenia and osteoporosis is very high in this cohort, said Dr. Eric P. Gall, chief of rheumatology and allergy at the Chicago Medical School, North Chicago.

"In my patient population, this is something that I"m well aware of and I tend to screen for osteoporosis sooner rather than later, particularly if there are anyother risk factors." said Dr. Gall during an audioconference on the subject or ganized by the American College of Rheumatology.

Additional complications of hypermobility include problems with proprioception, osteoarthritis, mitral valve prolapse, hernias, passing out, palpitations, chest pain, fatigue, and heat intolerance.

"These patients don't just complain of pain in their joints; they company of lots of things," he said. "They maybe have headaches and chronic pain. Sometimes pain disrupts their sleep and they get secondary fibromyalgia. [They could have] problems with sexual relations. They may have injuries and [psychological] reactions to the injuries. They have resistance to local anestheties."

One of the reasons why hypermobility can be difficult to diagnose is that patients may not always have pain in the affected joints. "If a patient has pain, they protect their joint and develop arthritis in the joint," he said, reducing range of motion and disguising the hypermobility. (For complete diagnostic criteria of hypermobility, see box.)

One specific type of hypermobile disease is Ehlers-Danlos syndrome, which has 10 subtypes, all characterized by slightly different associated comorbidities and risk factors. One of the most serious of these (type 4) may be fatal, but is also especially rare, with an estimated prevalence of 1 in 250,000, Dr. Gall said. Hallmark signs are vascular aneurysms, bowel and organ rupture, milder hyperexensibility compared with other types, translucent skin, pinched nose, dystrophic scars, and severe ecchymosis, which can often lead doctors to think that the sufferer is being physically abused.

"So how do we manage these people?" Dr. Gall asked. He mentioned that screening for mitral valve prolapse--both by listening and, if indicated, echocardiogram--is very important. "We discourage the hypermobile activities of daily living, although in the musician and the dancer we have to put practicality together ... and make compromises."

Additionally, physical therapy can help these patients, as can measures to protect fragile skin. Recurrent dislocations can be treated with surgery, but sutures must be placed very carefully and closely, and with "careful hemostasis."

"All [of the patients] who have severe disease are in need of genetic counseling" as well, he added.

Another serious hypermobility disease is Marfan syndrome. The criteria for a Marfan diagnosis is complicated, but Dr. Gall said that from a practical standpoint, if a patient's arm span measures more than 1.1 times his height, that is a good sign that Marfan syndrome may be present.

These patients can suffer complications like scoliosis, pectus excavaturm, and pectus carinatum, also known as a "pigeon chest." 'That can be so severe that it actually can compress the heart," Dr. Gall said. These patients also often have a high, arched palate. "You wouldn't see unless you looked for it," he said.

In Marfan syndrome, Ehlers-Danlos syndrome, and all hypermobility disorders, Dr. Gall emphasized that "management is multidisciplinary. People really have to work together as a team: The patient, the rheumatolo-gist, the orthopedist, and the primary care providers all need to work to- gether with the physical and occupational care therapist in dealing with these diseases.

"I have seen more and more [hypermobility] in patients that I see for other things ... but you have to look for them. You have to be aware of them," he said.

Patients with hypermobility often amaze others with their special skill, enabled by their joint laxity, in piano playing, ballet, and athletics. However this gift may become "a danger if we don't manage it appropriately," he warned.

Dr. Gall said he had no conflicts of interest to disclose in relation to his presentation. The conference was sponsored in part by the following pharmaceutical companies: Genentech Inc., Biogen Idec Inc., UCB Inc., Abbott Laboratories, Amgen Inc., Wyeth Pharmaceuticals, and Hoff-man-LaRoche Inc.

RELATED ARTICLE: Diagnosis Criteria for Hypermobility

Adiagnosis can be made if a paitent has both of the major criteria, or if the patient fulfills one major criteria and two minor criteria, or simply has four minor criteria. The Beighton hypermobility score assigns up to 9 points based on a patient's ability to bend and flex certain parts of the body.

Major criteria:

* A Beighton score of greater than 4 (out of 9).

* Arthralgias for longer than 3 months in more than four joints.

Minor criteria:

* A Beighton score of 1-3.

* Arthralgia in one to three joints.

* History of joint dislocation.

* More than three soft tissue lesions.

* Marfanoid habitus (tall and slim, with a spamheight ratio greater than 1.03, and an upper: lower segment ratio less than 0.89).

* Skin striae, hypermobility, or scarring.

* Lid laxity.

* History of varicosity, hernia, visceral prolapse.

Source: J. Bone Joint Surg. Br. 1969;51:444-53.

BY DENISE NAPOLI

Assistant Editor
COPYRIGHT 2008 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Rheumatology
Author:Napoli, Denise
Publication:Internal Medicine News
Geographic Code:1USA
Date:Jun 15, 2008
Words:837
Previous Article:Personality disorder influences alcohol relapse.
Next Article:Lupus patients have extremely low levels of vitamin D.
Topics:


Related Articles
Glucocorticoid users don't get DEXA, antiresorptive drugs. (Osteoporosis Risk).
Osteoporosis develops later in men, hits harder.
Strontium ranelate cuts vertebral fracture risk.
Low BMI helps identify poor bone health in men.
Consider risk factors in osteoporosis therapy: increased fracture risk seen in those with T scores below -1.8, previous fracture, and fair or poor...
Chemotherapy raises risk of osteoporosis.
Fracture risk assessment must be multifaceted.
Femoral BMD best predicts risk of vertebral fractures.
Fracture risk goes beyond bone mass.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters